Errors in insulin pump management can potentially result in severe hypoglycaemia, hyperglycaemia or DKA that may not be caught by typical hospital safeguards, such as pharmacy review or scheduled point‐of‐care testing. This evidence concerns the gene INS and Hypoglycemia.